Class 2 Recall on Seretide Accuhaler 250mcg 60DS

Class 2 Recall on Seretide Accuhaler 250mcg 60DS

Glaxo Wellcome UK Limited is recalling the above Lot of Seretide Accuhaler 50/250mcg because a manufacturing issue with this Lot has been identified which has resulted in a small number of units not delivering the full number of doses.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code Product Description Supplier Affected Batch
2602654 Seretide Accuhaler 250mcg 60DS GlaxoSmithKline UK Ltd 5K8W

For medical information enquiries, please contact GSK via customercontactuk@gsk.com, Live Chat facility on https://hcp.gsk.co.uk/contact-us/live-chat.html or by calling 0800 221 441 (option 4).

For stock enquiries, please refer to www.hcp.gsk.co.uk/supply.html or contact 0800 221 441 (option 1).


Recipients of this Drug Alert should bring it to the attention of relevant contacts.


Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.